The cohort companies are:

• D. Sole (d-sole.com) – D.Sole is a smart insole that utilizes multimodal sensors for the early detection and monitoring of foot complications, such as ulcers, in diabetic patients with neuropathy. The technology provides clinicians with critical data to proactively prevent severe ulcers and amputations, while also providing personalized care to diabetic patients.
• Ilant Health (ilanthealth.com) – Ilant Health is an obesity treatment company, focused on increasing access to obesity treatment while reducing the total cost of care for employers and payers. The company provides the single front door for individuals with obesity, delivering end-to-end evidence-based solutions (bariatric surgery, medication, intense behavioral therapy) through a technology-enabled and analytics-driven obesity medicine practice.
• Magnify Bioscience (magnifybiosci.com)– Magnify Biosciences Inc. empowers its customers by removing the traditional barriers to high-end nanoscale imaging. Their innovative Tissue Magnification technology enhances customers’ microscopes to accelerate biological discovery, offering profound insights that catalyze breakthroughs in both fundamental research and clinical applications.
• MetasTx (metastx.com) – MetasTx, LLC is developing novel diagnostics and therapeutics to treat and prevent metastatic cancer beginning with prostate cancer (PCa). The MetasTx platform is focused on PAK1, a target that has been demonstrated to be crucial for cancer cell initiation, proliferation, and metastasis. MetasTx is designing and developing novel chemicals to create a breakthrough, First-In-Class PAK1 inhibitor that will significantly improve patient survival and quality of life.
• Resilient LifeScience (http://www.resilient.bio) – Opioid overdose is the leading killer of Americans under 50, and roughly 80% of the 80,000 annual overdose deaths occur without a bystander to administer lifesaving naloxone. Resilient LifeScience is developing a wearable medical device to automatically detect and reverse an opioid overdose.
• Testa-Seat (testa-seat.com) – Testa-Seat is revolutionizing the manufacturing process of products for individuals with disabilities to create life-changing custom products in a sustainable and environmentally friendly way.

“The companies that have gone through the AlphaLab Health accelerator have been confronting and proposing solutions to some of medicine’s most complicated issues including addressing difficult issues regarding specific diseases, how social determinants of health impact patient’s response to disease, how hospitals operate and care for patients,” said Dr. Jeff Cohen, chief physician executive, community health and innovation for AHN. “Each company targets a unique problem and collaborates with AHN and Highmark staff affected by the problem. All the participants are striving to improve the future delivery of healthcare. This new cohort continues in this innovative vein, and we look forward to seeing how AlphaLab Health amplifies their outcomes.”

Each company in the fourth cohort will receive up to $100,000 in pre-seed investment, wet and dry lab space, one-on-one and group education sessions, and access to clinicians, hospital executives and other experts who can help these emerging companies succeed through the early stages of development.

“AlphaLab Health is central to our ongoing commitment to supporting life sciences companies in Southwest PA,” said Ven Raju, president and CEO of IW.

Ven continued, “AlphaLab Health supports life sciences companies with capital, deep domain expertise in conjunction with our partnership with Highmark-AHN and state-of-the-art facilities including wet lab space. The programming is designed to shepherd companies through the early stages of the business and development life cycle and provide companies with access to key networks such as investors, customers and mentors. The unique partnership between Highmark AHN and IW bring to bear the resources and know-how of a large integrated health system with that of a leading venture development organization to help early stage life sciences companies in the region. We are excited to welcome our 4th cohort of companies to the program.”

To learn more about AlphaLab Health, visit https://www.alphalabhealth.org/.

About the Allegheny Health Network:
Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community-based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 22,000 people, has more than 2,600 physicians on its medical staff, and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

About AlphaLab Health
AlphaLab Health (http://www.alphalabhealth.org) is a program of Innovation Works (IW) in partnership with Allegheny Health Network (AHN). IW and AHN bring their resources and expertise together to deliver greater value to health and life science related companies in the Pittsburgh region, nurturing innovations that will change health care and create growth for the regional economy. AlphaLab Health gives entrepreneurs access to specialized clinicians, insurers, hospital administrators and domain experts that accelerate the new company’s growth. The program links emerging companies with early customers, corporate partners, potential investors and knowledgeable staff and mentors so entrepreneurs can bring to life the innovations that will change and improve patient care.

About Innovation Works
Innovation Works (IW) is the region’s most active pre- and seed-stage investor and one of the most active early-stage investors across the country. Since 1999, IW has invested more than $24 million in life sciences companies and our life sciences portfolio has raised over $1.3 Billion in follow-on funding. In addition to providing investment through the only seed fund exclusively focused on the greater Pittsburgh region, Innovation Works has numerous programs and accelerators to advance high-potential startups in every type of technology: software, hardware, and life sciences. IW’s renowned AlphaLab accelerators (AlphaLab, AlphaLab Gear, and AlphaLab Heath) adapt to entrepreneurs’ time frames and educational needs with flexible start times, tailored programming, and entrepreneurially friendly investment terms. IW is the Southwestern PA Ben Franklin Technology Partner, a network of four statewide centers to advance innovation in Pennsylvania and partially funded through and overseen by the commonwealth’s Department of Community and Economic Development. For more information, go to https://www.innovationworks.org/.

Media Contact

Emily Beatty, Allegheny Health Network, 5136789620, [email protected], www.ahn.org

SOURCE Allegheny Health Network